End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
65.5 TWD | -1.21% | -1.80% | +12.74% |
03-19 | BIONET Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | BIONET Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Stem Cell-related Products and Gene Testing
90.3
%
| 884 | 90.1 % | 1,018 | 90.3 % | +15.19% |
Other
9.7
%
| 97 | 9.9 % | 109 | 9.7 % | +13.10% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Taiwan
98.5
%
| 960 | 98.0 % | 1,110 | 98.5 % | +15.57% |
Others
1.5
%
| 20 | 2.0 % | 17 | 1.5 % | -12.96% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tien Lai Liu
CEO | Chief Executive Officer | - | 31/08/06 |
Pei Yi Liu
DFI | Director of Finance/CFO | - | 22/03/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shao Hua Huang
BRD | Director/Board Member | 75 | 20/11/06 |
Cheng Hsien Tsai
CHM | Chairman | - | 31/07/00 |
Wen Cheng Chang
BRD | Director/Board Member | - | 10/04/03 |
Wen Hsi Yan
BRD | Director/Board Member | - | 27/06/06 |
Pao Hsi Sheng
BRD | Director/Board Member | - | 26/06/19 |
Shih Ming Liang
BRD | Director/Board Member | - | 25/10/07 |
Han Tung Chang
BRD | Director/Board Member | - | 27/06/06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 49,627,000 | 35,044,924 ( 70.62 %) | 2,330,000 ( 4.695 %) | 70.62 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+12.74% | 95.54M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+41.98% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- 1784 Stock
- Company BIONET Corp.